US company to produce millions of coronavirus vaccine doses by 2020's end

Pfizer, BioNtech and other companies are racing to develop a vaccine, since there are currently no approved treatments and only mixed results of medicines under study against the virus.

A researcher at the University of Pittsburgh works on a COVID-19 vaccine candidate, a fingertip-sized patch with dissolvable microscopic needles, in Pittsburgh, Pennsylvania, U.S.

(photo credit: REUTERS)

ByREUTERS

MAY 4, 2020 08:47

US company to produce millions of coronavirus vaccine doses by 2020's end

Pfizer, BioNtech and other companies are racing to develop a vaccine, since there are currently no approved treatments and only mixed results of medicines under study against the virus.

Emergency services respond to security incident at Heathrow

US envoy claims deal to end Russia-Ukraine war is 'close'